Complex Heart Procedure Study for High-Risk Patients
Part of Heart & circulation clinical trials.
This study tracks patients with weakened heart function who undergo complex stent procedures (PCI) instead of open-heart surgery. Researchers will follow your progress to understand how well these procedures work in patients who are too sick for traditional bypass surgery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Age 18 to 90 years old
- Heart function is weak (ejection fraction 35% or lower, or 40% or lower with severe valve problems)
- Need a complex stent procedure for multiple or blocked arteries, including severely calcified vessels or completely blocked arteries
- Either unable to have or unwilling to have bypass surgery, but your heart team believes stenting could help
- Not in immediate life-threatening shock and able to complete follow-up visits
- Able to understand the study and sign consent form
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is testing a robotic system to help with a procedure that opens blocked heart arteries. If you need a stent and fit the criteria, you may be able to join.
This study looks at treatment options for adults with significantly reduced heart pumping strength and extensive coronary artery disease. It may help people who are at higher risk due to widespread blocked heart arteries, but eligibility depends on recent heart events and bleeding risk.
This trial tests a temporary heart pump (called the KARDION Cory P4) used during a high-risk angioplasty (stenting) procedure. The pump helps keep blood flowing in patients whose heart is weak or who have complex blockages, aiming to make the procedure safer.
This study watches how people with complex or calcified heart artery disease are treated (with stents or bypass surgery) and how they do over time. It aims to learn which treatments work best for tough blockages.
This trial tests a device called Ventiflow LP that supports the heart during high-risk stent placement (PCI) in people whose hearts are weak or have complex blockages. It may be an option if surgery is too risky or you prefer not to have it.
This study compares two ways to improve blood flow in people with weakened heart pumping (ischemic cardiomyopathy): bypass surgery (CABG) versus stent treatment (PCI). It aims to see which approach works better when the heart still has enough at-risk muscle and when best medical therapy is already started.
Hear when a new Coronary artery disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.